Implantable Clip Improves Heart Function and Quality of Life
By HospiMedica International staff writers Posted on 12 Nov 2013 |
Image: The MitraClip clip delivery system (Photo courtesy of Abbott Vascular).
A new implantable clip helps patients suffering from degenerative mitral regurgitation who have a prohibitively high risk of complications from open-heart mitral valve surgery.
The MitraClip sytem includes three components: an 8 mm (24F) steerable guide catheter for percutaneous venous access; a clip delivery system that includes the implant attached to a highly maneuverable delivery catheter, with all controls at the proximal end; and the MitraClip device itself, a 4 mm-wide cobalt-chromium clip that is coated in polyester to promote tissue growth. The clip clamps to the mitral valve's two edges, holding them together. Since the heart beats normally during the procedure, the procedure does not require a heart-lung bypass machine.
Among the benefits of the device are a positive safety profile, reduction in mitral regurgitation, favorable left ventricular remodeling, improvement in patient symptoms, and reduction in hospitalizations for heart failure (HF). The clip can be used is magnetic resonance imaging (MRI) systems with a magnet strength of up to 3 Tesla. The MitraClip sytem is a product of Abbott Vascular (Abbott Park, NJ, USA), and has been approved by the US Food and Drug Administration (FDA).
“FDA approval of MitraClip marks an important milestone for Abbott as we continue to bring forward innovative therapies to help patients live better lives,” said Chuck Foltz, senior vice president of Abbott Vascular. “We look forward to making this technology available to specialized centers in the US with multidisciplinary teams experienced in the management of patients with heart valve disease, a model that facilitates dialogue across physician specialties and provides patients with the best treatment outcomes."
“As cardiac surgeons, we see patients with severe mitral regurgitation who we can technically operate on but who are just too frail or sick to survive mitral valve surgery with a reasonable risk and quality of life,” said Michael Mack, MD, director of cardiovascular research and surgery at Baylor Health Care System (Dallas, TX, USA). “With the MitraClip system, heart teams now have a catheter-based, less-invasive treatment option that can help patients who cannot withstand surgery regain their quality of life.”
Related Links:
Abbott Vascular
The MitraClip sytem includes three components: an 8 mm (24F) steerable guide catheter for percutaneous venous access; a clip delivery system that includes the implant attached to a highly maneuverable delivery catheter, with all controls at the proximal end; and the MitraClip device itself, a 4 mm-wide cobalt-chromium clip that is coated in polyester to promote tissue growth. The clip clamps to the mitral valve's two edges, holding them together. Since the heart beats normally during the procedure, the procedure does not require a heart-lung bypass machine.
Among the benefits of the device are a positive safety profile, reduction in mitral regurgitation, favorable left ventricular remodeling, improvement in patient symptoms, and reduction in hospitalizations for heart failure (HF). The clip can be used is magnetic resonance imaging (MRI) systems with a magnet strength of up to 3 Tesla. The MitraClip sytem is a product of Abbott Vascular (Abbott Park, NJ, USA), and has been approved by the US Food and Drug Administration (FDA).
“FDA approval of MitraClip marks an important milestone for Abbott as we continue to bring forward innovative therapies to help patients live better lives,” said Chuck Foltz, senior vice president of Abbott Vascular. “We look forward to making this technology available to specialized centers in the US with multidisciplinary teams experienced in the management of patients with heart valve disease, a model that facilitates dialogue across physician specialties and provides patients with the best treatment outcomes."
“As cardiac surgeons, we see patients with severe mitral regurgitation who we can technically operate on but who are just too frail or sick to survive mitral valve surgery with a reasonable risk and quality of life,” said Michael Mack, MD, director of cardiovascular research and surgery at Baylor Health Care System (Dallas, TX, USA). “With the MitraClip system, heart teams now have a catheter-based, less-invasive treatment option that can help patients who cannot withstand surgery regain their quality of life.”
Related Links:
Abbott Vascular
Latest Surgical Techniques News
- Intravascular Imaging Guidance System Optimizes Stenting Procedures for Improved Patient Outcomes
- Better-Designed Operating Room Shortens Surgical Procedure Time and Produces Better Outcomes
- Spatial Computing Technology Could Revolutionize Operating Room Environment
- Innovative Catheter Guidance Technology Aims for Zero Malpositioning
- Breakthrough Heart Valve Combines Best of Mechanical and Tissue Replacement Technology
- Ultraportable Battery Powered Medical Device Revolutionizes Concept of Portable Surgical Care
- Groundbreaking Tubular Scaffolds Enhance Bone Regeneration of Critical-Sized Skull Defects
- AI-Powered Precision Surgery Platform to Make Procedures Smarter and Safer
- Novel Magnet Compression Anastomosis Technology Ensures Fewer Complications, Bleeds or Leaks
- Cloud-Based AI Endoscopy System Assists Gastroenterologists in Detecting Suspected Colorectal Polyps
- Sperm-Like “Micro-Robots” Navigate Through Complex Environments for Minimally Invasive Surgery
- Stent Implantation Found Preferable for Previously Untreated Non-Complex Coronary Artery Disease
- Neuroendoscopy System Improves Outcome of Minimally Invasive Neurosurgical Procedures
- AI Platform Leverages Robotic Bronchoscopy Under 3D Fluoroscopic Guidance for Precision Biopsy
- New Implant Powers Healing After Spinal Cord Injury
- New Method Combines EEG, MRI, and ML to Identify Seizure-Prone Brain Regions Before Surgery